• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Genmab A/S

From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Steve Walker    December 14, 2017 December 14, 2017    No Comments on From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Many said good riddance to 2016 for biotech and pharma; things could only get better this year–and the European industry didn’t disappoint, says Labiotech.eu, the quintessential industry observer and news… Read more »

Corporate, Investment, Pharmaceuticals    Ablynx NV, Actelion Pharmaceuticals Ltd., ADC Therapeutics Sarl, Alnylam Pharmaceuticals Inc., Arzerra, Bicycle Therapeutics Ltd., Bioverativ Inc., Caplacizumab, CAR-T Therapies, Darzalex, Edwin Moses, ERYtech Pharma SA, Exscientia Ltd., Genmab A/S, Jan van de Winkel, Janssen Biotech Inc., Johnson & Johnson, Labiotech.eu, Novartis AG, Pierre-Olivier Goineau, Pyrrolobenzodiazepine, Rigontec GmbH, Sanofi SA, Yann Godfrin

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
  • And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea...well?...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress